Status:
RECRUITING
Premature Discontinuation of Contraceptive Implants
Lead Sponsor:
University of Colorado, Denver
Conditions:
Contraception Behavior
Eligibility:
FEMALE
14-23 years
Phase:
PHASE4
Brief Summary
To compare rates of etonogestrel implant discontinuation in implant initiators who are given advance provision of combined oral contraceptive pills (COCs) and a bleeding rescue regimen (COCR intervent...
Detailed Description
Objective: To compare rates of etonogestrel implant discontinuation in implant initiators who are given advance provision of combined oral contraceptive pills (COCs) and a bleeding rescue regimen (CO...
Eligibility Criteria
Inclusion
- You are between ages of 14 to 22.9 years.
- Started etonogestrel implant for the first time and have never used the implant before.
Exclusion
- There is any contraindication to estrogen containing birth control.
- Desire of pregnancy in next 12 months.
- Plans to move from the area in next 12 months and is not able to come to the clinic.
Key Trial Info
Start Date :
June 18 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT04828824
Start Date
June 18 2021
End Date
December 31 2025
Last Update
May 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital Colorado
Aurora, Colorado, United States, 80045